Inactive Instrument

News Diamyd Medical AB Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

2017	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
2017	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	17-08-27	CI
Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	17-08-10	CI
Sanofi Pasteur Inc. agreed to acquire Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others for $750 million	17-07-10	CI
Mertiva AB's Equity Buyback announced on December 6, 2012, has expired.	15-11-28	CI
Mertiva AB (OTCPK:DMYD.F) acquired an additional 0.54% stake in Protein Sciences Corporation for $0.62 million.	14-12-17	CI
Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	14-01-21	CI
Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	13-10-11	CI
The members of the management of Diamyd, Inc. cancelled the acquisition of 90% stake in Diamyd Inc. from Diamyd Medical AB (OM:DIAM B).	13-10-08	CI
Mertiva AB (OTCPK:DMYD.F) acquired an additional 7.27% stake in Protein Sciences Corporation from Pacific Rim Ventures Co., Ltd. and other shareholders for $8.4 million.	13-09-25	CI
Mertiva AB(NGM:MERT MTF) dropped from OMX Nordic All-Share Index	13-08-27	CI
Mertiva AB(NGM:MERT MTF) dropped from OMX Nordic Small Cap Index	13-07-30	CI
Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	13-07-04	CI
Diamyd Medical AB Announces Board Appointments	13-04-22	CI
Diamyd Medical AB Names Andreas Bergsten as Chief Executive Officer	13-04-22	CI
Diamyd Medical AB has Changed its Name to Mertiva AB	13-04-22	CI
Mertiva AB Plans to Appoint Andreas Bergsten as President	13-04-19	CI
Diamyd Medical AB Reports Group Earnings Results for the Second Quarter and Six Months Ended February 28, 2013	13-03-27	CI
Tranche Update on Diamyd Medical AB's Equity Buyback Plan announced on December 6, 2012.	13-03-27	CI
Östersjöstiftelsen, Endowment Arm sold 5.1% stake in Diamyd Medical AB (OM:DIAM B).	13-03-06	CI
Diamyd Medical AB Announces New Clinical Study with Diamyd's Diabetes Vaccine	13-01-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Diamyd Medical AB Nasdaq Stockholm

Equities

Summary

Filters